Perbedaan Indofarma Tbk. dan Super Bank Indonesia Tbk.: Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M), sedangkan Super Bank Indonesia Tbk. diperdagangkan di Rp505 (kapitalisasi pasar 17,11 T, volume 24 jam 11,9 jt). Perbedaan utamanya: Super Bank Indonesia Tbk. jauh lebih besar — sekitar 43,8× kapitalisasi pasar Indofarma Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| INAF | SUPA | |
|---|---|---|
Kapitalisasi Pasar | 390,51 M | 17,11 T |
Volume | — | 11,9 jt |
Lot | — | 119,04 rb |
Perputaran | — | 6 M |
Harga Rata-rata | — | 504,24 |
Nilai Transaksi | — | 6 M |
Harga Ekuilibrium Indikatif | — | 505 |
Volume Ekuilibrium Indikatif | — | 1,29 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →PT Super Bank Indonesia Tbk. (hereinafter referred to as the Bank) formerly under the name of PT Bank Fama International was established by Deed No. 36 on 5 March 1993, before Notary Herlien, S.H. The Bank has received a license as a commercial bank according to the Decree of the Minister of Finance of the Republic of Indonesia No. 834/KMK.017/1993 dated 11 October 1993.
Selengkapnya di halaman SUPA →